𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Development of myasthenia gravis during treatment of chronic hepatitis C with interferon-alpha and ribavirin

✍ Scribed by Christine J. Weegink; Robert A. F. M. Chamuleau; Henk W. Reesink; Delmar S. M. Molenaar

Publisher
Springer Japan
Year
2001
Tongue
English
Weight
35 KB
Volume
36
Category
Article
ISSN
0944-1174

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Pleural effusion associated with pegylat
Pleural effusion associated with pegylated interferon alpha and ribavirin treatment for chronic hepatitis C
✍ Amit Arora; Leonardo Vargas; Tomasz J. Kuzniar πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 128 KB

## Abstract Lung toxicity related to interferon (IFN) alpha typically takes a form of interstitial pneumonitis, granulomatous inflammation, or organizing pneumonia. We report a case of a 52‐year‐old woman, who developed pneumonitis with exudative, lymphocytic‐predominant pleural effusion following

Peripheral insulin resistance during tre
Peripheral insulin resistance during treatment of chronic hepatitis C with peguilated interferon plus ribavirin
✍ Vivianne Mello; Thomaz Cruz; Geila NuΓ±ez; Maria Tereza SimΓ΅es; Fabrizio Ney-Oliv πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 97 KB

Patients with hepatitis C virus (HCV) infection present higher risk of developing type-2 diabetes mellitus (DM). However, the mechanism of this association and the role of antiviral treatment are still unclear. The objective of this study was to investigate the relationship between the use of peguil